cyclohexanol has been researched along with jhw 015 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (90.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ihenetu, K; Molleman, A; Parsons, ME; Whelan, CJ | 1 |
| Ihenetu, K; Molleman, A; Parsons, M; Whelan, C | 1 |
| Duncan, M; Kendall, DA; Ralevic, V | 1 |
| Adams, M; Cassar, S; Daza, A; Kage, K; Meyer, M; Mukherjee, S; Whiteaker, K; Yao, BB | 1 |
| Ganju, RK; Ghosh, S; Groopman, JE; Preet, A | 1 |
| Del Rio, MJ; Velez-Pardo, C | 1 |
| Eisenach, JC; Romero-Sandoval, A | 1 |
| Deno, G; Fan, X; Gonsiorek, W; Hipkin, RW; Kozlowski, J; Lunn, CA | 1 |
| DeLeo, JA; Nutile-McMenemy, N; Romero-Sandoval, A | 1 |
| Bustamante, J; Jimenez-Del-Rio, M; Lores-Arnaiz, S; Velez-Pardo, C | 1 |
10 other study(ies) available for cyclohexanol and jhw 015
| Article | Year |
|---|---|
Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
Topics: Arachidonic Acids; Benzoxazines; Camphanes; Cannabinoids; Cell Survival; Cyclohexanols; Dose-Response Relationship, Drug; HT29 Cells; Humans; Immunoblotting; Indoles; Interleukin-8; Kinetics; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Tumor Necrosis Factor-alpha | 2003 |
Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
Topics: Arachidonic Acids; Benzoxazines; Camphanes; Cell Survival; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Humans; Indoles; Interleukin-2; Leukocytes, Mononuclear; Morpholines; Naphthalenes; Phytohemagglutinins; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2003 |
Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.
Topics: Animals; Benzofurans; Benzoxazines; Calcitonin Gene-Related Peptide; Camphanes; Cannabinoids; Capsaicin; Cyclohexanols; Dronabinol; Electric Stimulation; Indoles; Male; Mesenteric Arteries; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Rimonabant; Vasodilation | 2004 |
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors.
Topics: Animals; Arachidonic Acids; Benzoxazines; Binding, Competitive; Calcium; Cell Line; Chromones; Colforsin; Cyclic AMP; Cyclohexanols; DNA, Complementary; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Humans; Indoles; Morpholines; Naphthalenes; Polyunsaturated Alkamides; Radioligand Assay; Rats; Receptor, Cannabinoid, CB2; Species Specificity; Transfection; Tritium | 2004 |
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.
Topics: Calcium; Cannabinoids; Chemokine CXCL12; Chemokines, CXC; Chemotaxis, Leukocyte; Cyclohexanes; Cyclohexanols; Endothelium, Vascular; Humans; Immunosuppressive Agents; Indoles; Jurkat Cells; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinases; Phenols; Receptor, Cannabinoid, CB2; Receptors, CXCR4; Signal Transduction; T-Lymphocytes; Umbilical Veins | 2006 |
Avoidance of Abeta[(25-35)] / (H(2)O(2)) -induced apoptosis in lymphocytes by the cannabinoid agonists CP55,940 and JWH-015 via receptor-independent and PI3K-dependent mechanisms: role of NF-kappaB and p53.
Topics: Adult; Amyloid beta-Peptides; Apoptosis; Cannabinoids; Cyclohexanes; Cyclohexanols; Cytoprotection; Humans; Hydrogen Peroxide; Indoles; Lymphocytes; Male; NF-kappa B; Peptide Fragments; Phenols; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Receptors, Cannabinoid; Tumor Suppressor Protein p53 | 2006 |
Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision.
Topics: Animals; Cyclohexanes; Cyclohexanols; Indoles; Male; Neuroglia; Pain, Postoperative; Phenols; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Reflex; Spinal Cord | 2007 |
Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB2) in rodents and primates.
Topics: Animals; Binding, Competitive; Cell Membrane; Chemotaxis; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Dronabinol; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Macaca fascicularis; Mice; Quinolizines; Rats; Receptor, Cannabinoid, CB2; Species Specificity | 2007 |
Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury.
Topics: Animals; Behavior, Animal; Cyclohexanols; Drug Tolerance; Indoles; Male; Microglia; Oligodendroglia; Pain Measurement; Peripheral Nerve Injuries; Peripheral Nerves; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Spinal Cord | 2008 |
Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure.
Topics: Analgesics; Animals; Calcium; Cannabinoids; Cerebral Cortex; Cyclohexanols; Herbicides; Hydrogen Peroxide; Indoles; Membrane Potential, Mitochondrial; Mitochondria; Molecular Structure; Neuroprotective Agents; Oxidants; Paraquat; Rats; Superoxides | 2010 |